Mark A. King

39 papers receiving 1.7k citations

Mark A. King's Hit Papers

Phase II Trial of Sorafenib in Metastatic Thyroid Cancer 2009 · 456 citations
4560+5+11Years since publication100200300400

Peers

Mark A. King
Comparison fields: 5 of 100
  • Psychiatry and Mental health 444
  • Endocrinology, Diabetes and Metabolism 368
  • Emergency Medicine 101
  • Epidemiology 331
  • Pediatrics, Perinatology and Child Health 183
Replace Concetta Scazzone with:
Concetta Scazzone Italy
I‐Jun Chou Taiwan
Zian H. Tseng United States
GW Dec United States
Z Braf Israel
Valentina Mancini Italy
Richard N. Formica United States
Alessandro Neri Italy
Jacques Serratrice France
Z. N. Zakov United States
Mark A. King relative to Concetta Scazzone Italy Concetta Scazzone's profile →
Citations per field
00.5×2×3×4.4×
Concetta Scazzone · 1×
Citations per year

Countries citing papers authored by Mark A. King

Since Specialization
Citations

This map shows the geographic impact of Mark A. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. King more than expected).

Fields of papers citing papers by Mark A. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. King. The network helps show where Mark A. King may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark A. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. King Line = papers co-authored together Mark A. King links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1998473
2
Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
Hit paper breakdown →
2009456
3 2000270
4 201566
5 201154
6 199946
7 200545
8 200341
9 201534
10 199729
11 200221
12 199219
13 200119
14 199118
15 199618
16 200317
17 200416
18 199215
19 201212
20 201811

About Mark A. King

Mark A. King is a scholar working on Pulmonary and Respiratory Medicine, Psychiatry and Mental health, Surgery, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 39 papers that have together received 1.8k indexed citations. Recurring topics across this work include Epilepsy research and treatment (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Pleural and Pulmonary Diseases (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Cardiac tumors and thrombi (2 papers), Pericarditis and Cardiac Tamponade (2 papers), Trauma Management and Diagnosis (2 papers) and Infectious Diseases and Tuberculosis (2 papers). The work is most often cited by research in Psychiatry and Mental health (444 citations), Endocrinology, Diabetes and Metabolism (368 citations), Emergency Medicine (101 citations), Epidemiology (331 citations) and Pediatrics, Perinatology and Child Health (183 citations). Mark A. King has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Samuel Frank Berkovic, Mark R. Newton, Graeme D. Jackson, Greg J. Fitt, Mervyn Joseph Silvapulle, Lex A. Mitchell, Mark Damian Wewers, Thomas L. Clanton, Philip T. Diaz and Eric R. Pacht. Their work appears in journals such as Academic Radiology, Journal of Thoracic Imaging, The Annals of Thoracic Surgery, Epilepsia and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact